Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review

被引:8
作者
Farah, Line [1 ,2 ]
Borget, Isabelle [2 ,3 ,4 ]
Martelli, Nicolas [2 ,5 ]
Vallee, Alexandre [6 ]
机构
[1] Foch Hosp, Innovat Ctr Med Devices Dept, 40 Rue Worth, F-92150 Suresnes, France
[2] Univ Paris Saclay, Grp Rech & Accueil, Droit & Econ Sante Dept, Orsay, France
[3] Univ Paris Saclay, Dept Biostat & Epidemiol, Gustave Roussy, Villejuif, France
[4] Univ Paris Saclay, Equipe Labellisee Ligue Canc, Oncostat, Inserm,U1018, Villejuif, France
[5] Georges Pompidou European Hosp, Pharm Dept, Paris, France
[6] Foch Hosp, Dept Epidemiol & Publ Hlth, Suresnes, France
关键词
artificial intelligence; machine learning; health technology assessment; medical devices; evaluation; DATA PROTECTION; ASSESSMENT HTA; RECOMMENDATIONS; FRAMEWORK; SECURITY; LEGAL; INVOLVEMENT; PRIVACY; ISSUES; CARE;
D O I
10.2196/51514
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Artificial intelligence (AI)-based medical devices have garnered attention due to their ability to revolutionize medicine. Their health technology assessment framework is lacking. Objective: This study aims to analyze the suitability of each health technology assessment (HTA) domain for the assessment of AI -based medical devices. Methods: We conducted a scoping literature review following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta -Analyses) methodology. We searched databases (PubMed, Embase, and Cochrane Library), gray literature, and HTA agency websites. Results: A total of 10.1% (78/775) of the references were included. Data quality and integration are vital aspects to consider when describing and assessing the technical characteristics of AI -based medical devices during an HTA process. When it comes to implementing specialized HTA for AI -based medical devices, several practical challenges and potential barriers could be highlighted and should be taken into account (AI technological evolution timeline, data requirements, complexity and transparency, clinical validation and safety requirements, regulatory and ethical considerations, and economic evaluation). Conclusions: The adaptation of the HTA process through a methodological framework for AI -based medical devices enhances the comparability of results across different evaluations and jurisdictions. By defining the necessary expertise, the framework supports the development of a skilled workforce capable of conducting robust and reliable HTAs of AI -based medical devices. A comprehensive adapted HTA framework for AI -based medical devices can provide valuable insights into the effectiveness, cost-effectiveness, and societal impact of AI -based medical devices, guiding their responsible implementation and maximizing their benefits for and health care
引用
收藏
页数:18
相关论文
共 108 条
[1]   A reimbursement framework for artificial intelligence in healthcare [J].
Abramoff, Michael D. ;
Roehrenbeck, Cybil ;
Trujillo, Sylvia ;
Goldstein, Juli ;
Graves, Anitra S. ;
Repka, Michael X. ;
Silva, Ezequiel Zeke, III .
NPJ DIGITAL MEDICINE, 2022, 5 (01)
[2]   Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments [J].
Agboola, Foluso ;
Wright, Abigail C. ;
Herron-Smith, Serina ;
Mathur, Diya ;
Rind, David .
VALUE IN HEALTH, 2023, 26 (09) :1345-1352
[3]   The impact of artificial intelligence in medicine on the future role of the physician [J].
Ahuja, Abhimanyu S. .
PEERJ, 2019, 7
[4]   Organizational readiness for artificial intelligence in health care: insights for decision-making and practice [J].
Alami, Hassane ;
Lehoux, Pascale ;
Denis, Jean-Louis ;
Motulsky, Aude ;
Petitgand, Cecile ;
Savoldelli, Mathilde ;
Rouquet, Ronan ;
Gagnon, Marie-Pierre ;
Roy, Denis ;
Fortin, Jean-Paul .
JOURNAL OF HEALTH ORGANIZATION AND MANAGEMENT, 2021, 35 (01) :106-114
[5]   Artificial Intelligence and Health Technology Assessment: Anticipating a New Level of Complexity [J].
Alami, Hassane ;
Lehoux, Pascale ;
Auclair, Yannick ;
de Guise, Michele ;
Gagnon, Marie-Pierre ;
Shaw, James ;
Roy, Denis ;
Fleet, Richard ;
Ahmed, Mohamed Ali Ag ;
Fortin, Jean-Paul .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (07)
[6]   Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland [J].
Allen, Nicola ;
Walker, Stuart R. ;
Liberti, Lawrence ;
Salek, Sam .
VALUE IN HEALTH, 2017, 20 (03) :320-328
[7]   Explainability for artificial intelligence in healthcare: a multidisciplinary perspective [J].
Amann, Julia ;
Blasimme, Alessandro ;
Vayena, Effy ;
Frey, Dietmar ;
Madai, Vince I. .
BMC MEDICAL INFORMATICS AND DECISION MAKING, 2020, 20 (01)
[8]   Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment [J].
Angelis, Aris ;
Kanavos, Panos .
PHARMACOECONOMICS, 2016, 34 (05) :435-446
[9]  
[Anonymous], HTA core model
[10]  
artificialintelligenceact, EU Artificial Intelligence Act| Up-to-date developments and analyses of the EU AI Act